---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-265499"
form_type: "8-K"
ticker: "MO"
cik: "0000764180"
company_name: "ALTRIA GROUP, INC."
filed_at: "2022-10-20T23:59:59+00:00"
generated_at: "2026-06-23T02:28:38.161826+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# Altria to assign IQOS U.S. rights to PMI for $2.7B cash, effective April 2024

## Summary
- Altria receives $1B immediately and $1.7B (plus 6% interest) by July 15, 2023 from PMI subsidiary Triaga.
- IQOS exclusive U.S. commercialization rights assigned to PMI effective April 30, 2024.
- IQOS currently unavailable in U.S. due to ITC import ban; PMI targets supply resumption in H1 2023.
- Altria will record $2.7B as deferred gain in Q4 2022, recognized in earnings upon assignment.
- Altria gains flexibility to invest in other smoke-free products; expects to finalize two product designs by end of 2022.

## SEC filing metadata
- accession: 0001193125-22-265499
- form_type: 8-K
- ticker: MO
- cik: 0000764180
- company_name: ALTRIA GROUP, INC.
- filed_at: 2022-10-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/764180/000119312522265499/0001193125-22-265499-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/764180/000119312522265499/d361503d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-265499
- JSON: https://secwatch.observer/filing/0001193125-22-265499.json
- Plain text: https://secwatch.observer/filing/0001193125-22-265499.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.